ALKEM: Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% st… as shares jumped +3.4%
Alkem Laboratories ended Wednesday's session at ₹5,348.50, up 3.35% on the previous close of ₹5,175. The stock opened flat, slipped to an intraday low of ₹5,161.50, and then spent the rest of the day climbing, reaching ₹5,361 before settling just under that mark. The wider market barely moved by comparison — the Nifty finished 0.23% higher — so this was a stock-specific bid rather than a sector or index drift. Turnover backed the move: volume ran at roughly 1.75 times the stock's usual pace for this point in the day.
The derivatives footprint pointed the same way. Alkem's futures were classified as a long buildup at the last close — fresh positions opened on the long side, visible as open interest rising 4.97% while the price ticked up 0.17%. Through today's session the futures contract held a premium of 0.92% over the cash price, and the stock traded 0.97% above its volume-weighted average price, the benchmark that shows whether buyers or sellers controlled the day's average fill. Both are consistent with demand rather than short covering, though neither proves it.
There was nothing on the institutional or insider record to anchor the move. No bulk or block deals were reported in the stock today, none appear in the past 30 days, and there were no insider filings in the past 60 days. The only large transaction on file is well outside that window: 107 days ago, according to a report from Moneycontrol, a block deal was executed at Rs 5,200 per share, with a 1.5% stake changing hands for Rs 930 crore. That is history, not a driver for today.
The technical picture stayed mixed despite the jump. The 14-day RSI, a momentum gauge that runs from 0 to 100, sat at 53.4 — squarely neutral. The stock remained below both its 50-day and 200-day moving averages, with no golden cross, no death cross, no Darvas box breakout and no trend-template qualification. It closed 9.86% under its 52-week high and 5.89% above its 52-week low. The past week is up 4.07%, but the past month is still down 2.31%.
News flow offers little. Only one item is fresh, and it is circular: a Business Standard piece from about two hours earlier noting that the stock "spurts 2.36%" — a report of the move, not an explanation of it. The substantive company news is a month old, including an NDTV Profit report that Q1 net profit dropped 22% despite revenue growth, and a note that the trading window reopened on August 17.
The data does not establish a single driver for the move. What is on the record is a long buildup in futures, a futures premium, above-average volume and a close near the day's high — the footprints of buying — with no disclosed deal, filing or announcement dated today to explain who was doing it or why.
The numbers
- Last price ₹5,348.50, +3.35% on the day
- Day range ₹5,161.50 – ₹5,361.00
- NIFTY moved +0.23% the same session
Signals that fired
- At day's high
- Futures premium +0.92%
- Above VWAP +0.97%
- Long Buildup (last close)
F&O positioning
Futures classified as Long Buildup — open interest +5.0% with price +0.2% in the latest bhavcopy.
Technical context
Volume ran at 1.8× its 20-day average; rsi(14) sits at 53; price is 9.9% from the 52-week high.
Recent headlines
- Alkem Laboratories Ltd spurts 2.36% — Business Standard (2h ago)
- Alkem Laboratories Share Price rises 2.22%: key analysis — Univest (2d ago)
- Alkem Laboratories Ltd. Shareholding Pattern – Promoters, FIIs & DIIs — valueresearchonline.com (13d ago)
- Alkem Laboratories Ltd (BOM:539523) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth ... — GuruFocus.com (33d ago)
- Alkem Laboratories trading window opens on August 17 — scanx.trade (34d ago)
- Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth — NDTV Profit (34d ago)
- Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside — Yahoo Finance (35d ago)
- Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore — Moneycontrol.com (107d ago)
Sources
- Alkem Laboratories Ltd spurts 2.36% — Business Standard
- Alkem Laboratories Share Price rises 2.22%: key analysis — Univest
- Alkem Laboratories Ltd. Shareholding Pattern – Promoters, FIIs & DIIs — valueresearchonline.com
- Alkem Laboratories Ltd (BOM:539523) (Q1 2027) Earnings Call Highlights: Robust Revenue Growth ... — GuruFocus.com
- Alkem Laboratories trading window opens on August 17 — scanx.trade
- Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth — NDTV Profit
- Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Q1 2027 -- GF Value Sees 26% Upside — Yahoo Finance
- Alkem Laboratories block deal executed at Rs 5,200 per share; 1.5% stake sold for Rs 930 crore — Moneycontrol.com
Keep digging
- ALKEM — full smart-money page: F&O positioning, deals, insider filings and option chain in one place.
- Today's screens: every stock matching the same setups (buildups, breakouts, volume shockers).
- Newsroom: the other stocks in play this session.